Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of real-world kidney outcomes with predicted outcomes at the time of diagnosis and post-biopsy in a cohort of children with IgA nephropathy.

Jornal brasileiro de nefrologia·2025
Same author

Metabolic Myopathies: Experience of a Reference Center of Inherited Metabolic Diseases.

Endocrine, metabolic & immune disorders drug targets·2023
Same author

A Novel Genetic Variant in <i>MBD5</i> Associated with Severe Epilepsy and Intellectual Disability: Potential Implications on Neural Primary Cilia.

International journal of molecular sciences·2023
Same author

Cerebral Malaria and Cytotoxic Lesions of the Corpus Callosum.

The Pediatric infectious disease journal·2023
Same author

Dysphagia and Tongue Deviation: An Unexpected Cause.

The Pediatric infectious disease journal·2022
Same author

Adding evidence to the role of NEUROG1 in congenital cranial dysinnervation disorders.

Clinical genetics·2021

Related Experiment Video

Updated: Jul 1, 2026

Mouse Models of Periventricular Leukomalacia
06:24

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

Lupus myelopathy in a child.

José Pedro Vieira1, Oscar Ortet, Deolinda Barata

  • 1Neurology Department, Hospital de Dona Estefânia, Lisbon, Portugal.

Pediatric Neurology
|November 19, 2002
PubMed
Summary

This case study highlights a rare instance of lupus myelopathy in a young child, presenting with neurological symptoms and kidney issues. Early diagnosis and treatment are crucial for managing this severe complication of systemic lupus erythematosus.

More Related Videos

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

Related Experiment Videos

Last Updated: Jul 1, 2026

Mouse Models of Periventricular Leukomalacia
06:24

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

Area of Science:

  • Pediatric Neurology
  • Rheumatology
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organ systems.
  • Neurological complications, such as lupus myelopathy, are serious manifestations of SLE, particularly in pediatric cases.
  • Transverse myelopathy involves inflammation across the spinal cord, leading to neurological deficits.

Observation:

  • A 5-year-old female presented with prolonged fever, anorexia, weight loss, and a transient skin rash.
  • She subsequently developed acute transverse myelopathy with partial motor and sensory recovery.
  • Laboratory findings included positive antinuclear and anti-double-stranded DNA antibodies, but negative antiphospholipid antibodies.
  • Massive proteinuria indicated subsequent lupus nephritis, requiring treatment with steroids and cyclophosphamide.

Findings:

  • The patient exhibited a rare presentation of lupus myelopathy at a very young age.
  • Magnetic resonance imaging (MRI) findings, clinical presentation, and laboratory results were consistent with lupus myelopathy.
  • The co-occurrence of myelopathy and lupus nephritis underscores the systemic nature of the disease.

Implications:

  • This case emphasizes the importance of considering lupus myelopathy in the differential diagnosis of acute myelopathy in children, even in the absence of antiphospholipid antibodies.
  • Prompt recognition and management of SLE-related neurological complications are vital for improving patient outcomes.
  • Further research into the pathogenesis and treatment of pediatric lupus myelopathy is warranted.